Latanoprost + Netarsudil (Roclanda)

Status:

Red

Decision Date:

November 2024

Comments

RED: NICE TA1009: Latanoprost–netarsudil for previously treated primary open-angle glaucoma or ocular hypertension. (Decision date November 2024)

Red Drug Classifications

• 5: Is new to clinical practice and unfamiliar, necessitating a period of accumulation of experience, firstly (and most rapidly) by consultants/specialists

search again